Alpha interferon induces distinct translational control programs to suppress hepatitis C virus RNA replication

Area of Science:

• Virology
• Molecular Biology
• Immunology

Background:

• Hepatitis C virus (HCV) infection is a global health concern treated with interferon (IFN)-based therapies.
• The precise mechanisms by which IFN suppresses HCV replication and how the virus evades this response remain unclear.
• Understanding these mechanisms is crucial for improving antiviral strategies.

Purpose of the Study:

• To elucidate the molecular mechanisms underlying IFN's suppression of HCV replication.
• To investigate the role of NS5A protein variants in mediating resistance to IFN.
• To identify cellular factors involved in IFN-mediated translational control of HCV.

Main Methods:

• Utilized metabolic labeling experiments to assess viral protein stability and translation.
• Analyzed HCV RNA replication and internal ribosome entry site (IRES) function in IFN-treated cells.
• Examined ribosome distribution and cellular protein associations with viral translation complexes.
• Investigated the function of NS5A variants and P56 protein in HCV translation.

Main Results:

• IFN specifically blocked HCV RNA translation, suppressing viral replication.
• NS5A variants inhibiting protein kinase R (PKR) reduced eIF2alpha phosphorylation, enhancing viral protein synthesis and replication.
• The cellular protein P56 was identified as an eIF3-associated factor that suppresses HCV IRES function.
• P56's suppressive activity was dependent on its interaction with eIF3.

Conclusions:

• IFN inhibits HCV replication by targeting translational control pathways.
• PKR and P56 are key mediators of IFN's antiviral action, affecting eIF2 and eIF3-dependent translation initiation steps, respectively.
• These findings provide insights into HCV's resistance mechanisms and potential therapeutic targets.